• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Vericel Corporation - Common Stock (NQ:VCEL)

    47.70 +0.70 (+1.48%)
    Streaming Delayed Price Updated: 3:30 PM EDT, Jul 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Vericel Corporation - Common Stock

    < Previous 1 2 3 Next >
    News headline image
    Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
    From Biotech Insider
    Via GlobeNewswire
    News headline image
    The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
    From World Street Intelligence
    Via GlobeNewswire
    News headline image
    Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
    From Energy Metal News
    Via GlobeNewswire
    News headline image
    Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Present at Multiple Upcoming Investor Conferences
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel Announces Preliminary 2025 Financial Results and Business Updates
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel Reports Third Quarter 2025 Financial Results
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Report Third-Quarter 2025 Financial Results on November 6, 2025
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel Reports Second Quarter 2025 Financial Results
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Present at Multiple Upcoming Investor Conferences
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel Reports Third Quarter 2024 Financial Results
    From Vericel Corporation
    Via GlobeNewswire
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.